Nucleotica Participates in CMEF 2025, One of the World’s Largest Medical Equipment Fairs
Nucleotica is pleased to announce its participation in the China International Medical Equipment Fair (CMEF) Spring 2025, held from April 8 to 11, 2025, at the National Exhibition and Convention Center in Shanghai.
Representing Nucleotica at the event were Medical Director Andrei Babenka and Director of International Sales Sergey Yetka, who engaged with global partners and industry leaders to showcase the company's latest innovations in molecular diagnostics.
Founded in 1979, CMEF is one of the largest and most influential exhibitions of medical equipment and technology in the world. The Spring 2025 edition featured over 5,000 exhibitors and attracted more than 310,000 healthcare professionals, including hospital administrators, clinicians, biomedical engineers, researchers, and medical technology distributors.
At this year’s event, Nucleotica presented its advanced platform for DNA and RNA-based diagnostics, designed to bring unprecedented speed and sensitivity to the detection of somatic mutations and infectious diseases. The company’s solutions are aimed at enabling precision diagnostics and personalized treatment pathways, particularly in oncology and critical care.
“CMEF provided an excellent opportunity to connect with strategic partners and decision-makers in the medical technology space,” said Sergey Yetka. “We were proud to share our technology with a global audience and explore opportunities to expand Nucleotica’s impact across Asia and beyond.”
“We see tremendous demand for accurate and scalable diagnostic tools,” added Andrei Babenka. “Participation in CMEF reinforces our commitment to international collaboration and to improving clinical outcomes worldwide.”
Beyond the exhibition floor, CMEF 2025 featured a dynamic lineup of seminars, panels, and workshops, offering insights into current trends and advancements in medical imaging, diagnostics, digital health, and more.
